1. Home
  2. JANX
  3. JANX News

Latest Janux Therapeutics Inc. (JANX) News on September 19, 2025

JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target
JANX

Insider Monkey

3 months ago

JonesTrading Remains Bullish on Janux Therapeutics (JANX) With a $90 Price Target

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer
JANX

Business Wire

4 months ago

Janux Therapeutics Appoints Janeen Doyle as Chief Corporate and Business Development Officer

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights
JANX

Business Wire

4 months ago

Janux Therapeutics Reports First Quarter 2025 Financial Results and Business Highlights

Janux commences Phase Ib studies in trial for prostate cancer treatment
JANX

Clinical Trials Arena

4 months ago

Janux commences Phase Ib studies in trial for prostate cancer treatment

Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential
JANX

Insider Monkey

4 months ago

Janux Therapeutics, Inc. (JANX): Among Unknown Billionaire Phill Gross’ Stock Picks with Huge Upside Potential

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates
JANX

Business Wire

4 months ago

Janux Therapeutics Initiates Phase 1b Expansion Studies with JANX007 in Patients with Prostate Cancer and Provides Program Updates

Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?
JANX

Insider Monkey

4 months ago

Is Janux Therapeutics, Inc. (JANX) the Best Small Cap Stock to Buy with the Biggest Upside Potential?

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?
JANX

Insider Monkey

6 months ago

Is Janux Therapeutics Inc. (NASDAQ:JANX) the Best Up and Coming Stock to Buy According to Wall Street Analysts?

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode?
JANX

Insider Monkey

6 months ago

Is Janux Therapeutics, Inc. (NASDAQ:JANX) the Best Small Cap Stock to Buy Before They Explode?

Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March
JANX

Insider Monkey

6 months ago

Janux Therapeutics, Inc. (JANX): Among Stocks Receiving the Most Insider Love in March

We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow
JANX

Simply Wall St.

6 months ago

We're Interested To See How Janux Therapeutics (NASDAQ:JANX) Uses Its Cash Hoard To Grow

Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy?
JANX

Insider Monkey

6 months ago

Is Janux Therapeutics (JANX) a Worst High-Risk High-Reward Growth Stock to Buy?

WEX, Lamb Weston, and More Stocks See Action From Activist Investors
JANX

Barrons.com

6 months ago

WEX, Lamb Weston, and More Stocks See Action From Activist Investors

Biotech Alert: Searches spiking for these stocks today
JANX

TipRanks

6 months ago

Biotech Alert: Searches spiking for these stocks today

Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently
JANX

Insider Monkey

6 months ago

Janux Therapeutics, Inc. (JANX): Among The Stocks With At Least $30 Million In Insider Spending Recently

Janux Therapeutics price target lowered to $41 from $62 at Scotiabank
JANX

TipRanks

7 months ago

Janux Therapeutics price target lowered to $41 from $62 at Scotiabank

JANX

MT Newswires

7 months ago

Wedbush Adjusts Price Target on Janux Therapeutics to $76 From $75, Maintains Outperform Rating

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights
JANX

Business Wire

7 months ago

Janux Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Business Highlights

Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now
JANX

Insider Monkey

7 months ago

Janux Therapeutics, Inc. (JANX): Among the Oversold Biotech Stocks to Buy Now

JANX

MT Newswires

8 months ago

Janux Therapeutics Promotes Zachariah McIver to Chief Medical Officer

JANX

Business Wire

8 months ago

Janux Therapeutics Promotes Zachariah McIver, D.O., Ph.D. to Chief Medical Officer

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million
JANX

Business Wire

9 months ago

Janux Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Pre-Funded Warrants Including Full Exercise of Underwriters’ Option to Purchase Additional Shares for Total Gross Proceeds of $402.5 Million

JANX

MT Newswires

9 months ago

Janux Therapeutics Prices $350 Million Offering of Shares, Warrants

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants
JANX

Business Wire

9 months ago

Janux Therapeutics Announces Pricing of $350.0 Million Underwritten Public Offering of Common Stock and Pre-Funded Warrants

Why Janux Therapeutics Crushed the Market Today
JANX

Motley Fool

9 months ago

Why Janux Therapeutics Crushed the Market Today

JANX Stock Hits Record High on Prostate Cancer Study Data
JANX

Zacks

9 months ago

JANX Stock Hits Record High on Prostate Cancer Study Data

JANX

MT Newswires

10 months ago

Janux Therapeutics Launches $300 Million Offering

Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride
JANX

Investor's Business Daily

10 months ago

Janux Catapults 49% On 'Unprecedented' Results In Prostate Cancer; Vir Goes For A Ride

Janux Therapeutics Announces Proposed Public Offering
JANX

Business Wire

10 months ago

Janux Therapeutics Announces Proposed Public Offering

JANX

MT Newswires

10 months ago

Sector Update: Health Care Stocks Mixed Late Afternoon

JANX

MT Newswires

10 months ago

Sector Update: Health Care Stocks Higher Tuesday Afternoon

JANX

MT Newswires

10 months ago

Sector Update: Health Care

JANX

MT Newswires

10 months ago

Janux Therapeutics Shares Soar After Reporting 'Positive' Interim Data for JANX007 in Prostate Cancer Patients

Janux Rockets 41% in Five Days as Cancer Breakthrough Fuels Market Buzz
JANX

GuruFocus.com

10 months ago

Janux Rockets 41% in Five Days as Cancer Breakthrough Fuels Market Buzz

Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results
JANX

Barrons.com

10 months ago

Janux Therapeutics Stock Soars on Prostate Cancer Drug Trial Results

JANX

GuruFocus.com

10 months ago

Janux Skyrockets: 69% Surge This Morning Leads to 650% Gain in a Year

Janux, Vir Catapult On 'Unprecedented' Results In Prostate Cancer Patients
JANX

Investor's Business Daily

10 months ago

Janux, Vir Catapult On 'Unprecedented' Results In Prostate Cancer Patients

JANX

MT Newswires

10 months ago

Scotiabank Raises Price Target on Janux Therapeutics to $62 From $42, Keeps Sector Perform Rating

JANX

MT Newswires

10 months ago

Top Premarket Gainers

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC
JANX

Business Wire

10 months ago

Janux Announces Doses Selected for Phase 1b Expansion Trials Supported by Encouraging Efficacy and Safety Profile Observed in Phase 1a Dose Escalation for JANX007 in mCRPC

JANX

MT Newswires

10 months ago

Janux Therapeutics Insider Sold Shares Worth $1,289,879, According to a Recent SEC Filing

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies
JANX

Business Wire

10 months ago

Janux Therapeutics to Host Virtual Event Discussing Updated Clinical Data in Phase 1a Dose Escalation for JANX007 in mCRPC and Doses Selected for Phase 1b Expansion Studies

Janux Therapeutics initiated with an Outperform at Leerink
JANX

TipRanks

10 months ago

Janux Therapeutics initiated with an Outperform at Leerink

JANX

MT Newswires

10 months ago

Leerink Initiates Janux Therapeutics at Outperform With $79 Price Target

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors
JANX

Barrons.com

10 months ago

Bitdeer Technologies, PBF Energy, and More Stocks See Action From Activist Investors

Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations
JANX

Simply Wall St.

10 months ago

Janux Therapeutics Third Quarter 2024 Earnings: Misses Expectations

JANX

MT Newswires

10 months ago

Wedbush Adjusts Janux Therapeutics Price Target to $75 From $74, Maintains Outperform Rating

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights
JANX

Business Wire

10 months ago

Janux Therapeutics Reports Third Quarter 2024 Financial Results and Business Highlights

Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors
JANX

Barrons.com

a year ago

Bath & Body Works, Paramount Global, and More Stocks See Action From Activist Investors

JANX

MT Newswires

a year ago

UBS Initiates Janux Therapeutics With Buy Rating, $69 Price Target

Paradigm Biocapital Advisors LP Acquires Shares in Janux Therapeutics Inc
JANX

GuruFocus.com

a year ago

Paradigm Biocapital Advisors LP Acquires Shares in Janux Therapeutics Inc

RA Capital Management Reduces Stake in Janux Therapeutics
JANX

GuruFocus.com

a year ago

RA Capital Management Reduces Stake in Janux Therapeutics

JANX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/21/2024

Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business
JANX

Simply Wall St.

a year ago

Janux Therapeutics (NASDAQ:JANX) Is In A Strong Position To Grow Its Business

Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now
JANX

Insider Monkey

a year ago

Janux Therapeutics, Inc. (JANX): A Hot Stock to Buy Now

JANX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 10/01/2024

JANX

MT Newswires

a year ago

Janux Therapeutics Insider Sold Shares Worth $2,297,755, According to a Recent SEC Filing

JANX

MT Newswires

a year ago

Janux Therapeutics Insider Sold Shares Worth $1,157,641, According to a Recent SEC Filing

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?
JANX

Insider Monkey

a year ago

Is Janux Therapeutics Inc. (JANX) the Best Performing Small-Cap Stock in 2024?

Lennar, Bitdeer, and More Stocks See Action From Activist Investors
JANX

Barrons.com

a year ago

Lennar, Bitdeer, and More Stocks See Action From Activist Investors

JANX

GuruFocus.com

a year ago

RA Capital Management L.P. Increases Stake in Janux Therapeutics Inc

Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks
JANX

Insider Monkey

a year ago

Janux Therapeutics, Inc. (JANX): Among Hedge Funds’ Top Biotech Stock Picks

JANX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/13/2024

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?
JANX

Zacks

a year ago

Janux Therapeutics (JANX) Moves 6.5% Higher: Will This Strength Last?

JANX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 09/11/2024

JANX

MT Newswires

a year ago

Stifel Nicolaus Initiates Coverage on Janux Therapeutics With Buy Rating, $70 Price Target

Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors
JANX

Barrons.com

a year ago

Southwest Airlines, Rocket Lab USA, and More Stocks See Action From Activist Investors

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates
JANX

Zacks

a year ago

Janux Therapeutics, Inc. (JANX) Reports Q2 Loss, Tops Revenue Estimates

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights
JANX

Business Wire

a year ago

Janux Therapeutics Reports Second Quarter 2024 Financial Results and Business Highlights

Janux Therapeutics Announces Updates to Board of Directors
JANX

Business Wire

a year ago

Janux Therapeutics Announces Updates to Board of Directors

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors
JANX

Barrons.com

a year ago

TruBridge, Evans Bancorp, and More Stocks See Action From Activist Investors

Lotto 6/49 - $64 million up for grabs in the next draw!
JANX

CNW Group

a year ago

Lotto 6/49 - $64 million up for grabs in the next draw!

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture
JANX

Simply Wall St.

a year ago

Returns On Capital At B&S Group (AMS:BSGR) Paint A Concerning Picture

Seoul says it will resume loudspeaker propaganda against North
JANX

AFP

a year ago

Seoul says it will resume loudspeaker propaganda against North

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend
JANX

Simply Wall St.

a year ago

It Might Not Be A Great Idea To Buy PATRIZIA SE (ETR:PAT) For Its Next Dividend

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m
JANX

Simply Wall St.

a year ago

OUTsurance Group Insiders Placed Bullish Bets Worth R25.5m

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week
JANX

Barrons.com

a year ago

Fed Meeting, Inflation Report, Apple’s WWDC, Broadcom Earnings, and More to Watch This Week

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend
JANX

Simply Wall St.

a year ago

Just Three Days Till BREMER LAGERHAUS-GESELLSCHAFT -Aktiengesellschaft von 1877- (FRA:BLH) Will Be Trading Ex-Dividend

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued
JANX

Simply Wall St.

a year ago

An Intrinsic Calculation For ORIOR AG (VTX:ORON) Suggests It's 35% Undervalued

JANX

Argus Research

a year ago

Daily – Vickers Top Buyers & Sellers for 06/06/2024

JANX

MT Newswires

a year ago

Janux Therapeutics Insider Sold Shares Worth $45,043,975, According to a Recent SEC Filing

JANX

MT Newswires

a year ago

Janux Therapeutics Insider Sold Shares Worth $82,125,000, According to a Recent SEC Filing

JANX

MT Newswires

a year ago

Scotiabank Starts Janux Therapeutics With Sector Perform Rating

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate
JANX

Simply Wall St.

a year ago

We're Not Very Worried About Janux Therapeutics' (NASDAQ:JANX) Cash Burn Rate

JANX

MT Newswires

a year ago

Wedbush Raises Janux Therapeutics' PT to $74 From $53, Keeps Outperform Rating

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates
JANX

GuruFocus.com

a year ago

Janux Therapeutics Reports Narrower Q1 Loss, Misses Revenue Estimates

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights
JANX

Business Wire

a year ago

Janux Therapeutics Reports First Quarter 2024 Financial Results and Business Highlights

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength
JANX

Zacks

a year ago

Here's What Could Help Janux Therapeutics (JANX) Maintain Its Recent Price Strength

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors
JANX

Zacks

a year ago

Janux (JANX) Rises Almost 50% in a Week on Buyout Rumors

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable
JANX

Zacks

a year ago

Janux Therapeutics (JANX) is on the Move, Here's Why the Trend Could be Sustainable

Why Janux Therapeutics Stock Is Crushing It This Week
JANX

Motley Fool

a year ago

Why Janux Therapeutics Stock Is Crushing It This Week

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?
JANX

Benzinga

a year ago

Why Is Cancer-Focused Janux Therapeutics Stock Trading Higher On Thursday?

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet
JANX

Zacks

a year ago

Wall Street Analysts Think Janux Therapeutics (JANX) Could Surge 40.3%: Read This Before Placing a Bet

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options
JANX

Investor's Business Daily

a year ago

Biotech Stocks Heat Up As Arvinas Scores Novartis Licensing Pact, Janux Reportedly Explores Options

Why Janux Therapeutics Stock Soared as the Market Sagged Today
JANX

Motley Fool

a year ago

Why Janux Therapeutics Stock Soared as the Market Sagged Today

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)
JANX

Zacks

a year ago

After Plunging -11.78% in 4 Weeks, Here's Why the Trend Might Reverse for Janux Therapeutics (JANX)

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know
JANX

Zacks

a year ago

Janux Therapeutics (JANX) Upgraded to Buy: Here's What You Should Know

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade
JANX

Zacks

a year ago

Wall Street Analysts Believe Janux Therapeutics (JANX) Could Rally 57.47%: Here's is How to Trade

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst
JANX

Benzinga

a year ago

Cancer-Focused Janux Therapeutics Platform Has 'Tremendous Opportunity': Analyst

2 Stocks That Have More Than Tripled This Year: Are They Buys?
JANX

Motley Fool

2 years ago

2 Stocks That Have More Than Tripled This Year: Are They Buys?

Share on Social Networks: